# A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors

> **NCT07104877** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 25 (actual)

## Conditions studied

- Colorectal Cancer
- Gastric Cancer (GC)
- Gastrointestinal Tumors

## Interventions

- **DRUG:** SYS6010
- **DRUG:** SYH2051

## Key facts

- **NCT ID:** NCT07104877
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-18
- **Primary completion:** 2024-11-01
- **Final completion:** 2026-04-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07104877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07104877, "A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07104877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*